GSK Ebola vaccine trial seen moving to wider phase in February
December 19, 2014 at 06:30 AM EST
GENEVA, Dec 19 (Reuters) - Trials of GlaxoSmithKline's experimental Ebola vaccine are likely to move to a second phase in February, later than previously suggested, after a meeting of national regulators said they needed more information.
